BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2747772)

  • 1. Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients.
    Luque RM; López-Sánchez LM; Villa-Osaba A; Luque IM; Santos-Romero AL; Yubero-Serrano EM; Cara-García M; Álvarez-Benito M; López-Mirand A J; Gahete MD; Castaño JP
    Oncotarget; 2017 Oct; 8(46):81462-81474. PubMed ID: 29113405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management of women at increased risk for breast cancer.
    Vogel VG; Yeomans A; Higginbotham E
    Breast Cancer Res Treat; 1993 Nov; 28(2):195-210. PubMed ID: 8173071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen therapy during menopause. Practical treatment recommendations.
    Sitruk-Ware R
    Drugs; 1990 Feb; 39(2):203-17. PubMed ID: 2183999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis after 60.
    Smith R
    BMJ; 1990 Sep; 301(6750):452-3. PubMed ID: 2119835
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone replacement therapy--a survey of perimenopausal women in a community setting.
    Kadri AZ
    Br J Gen Pract; 1991 Mar; 41(344):109-12. PubMed ID: 2031753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and survival after surgery for ovarian cancer.
    Eeles RA; Tan S; Wiltshaw E; Fryatt I; A'Hern RP; Shepherd JH; Harmer CL; Blake PR; Chilvers CE
    BMJ; 1991 Feb; 302(6771):259-62. PubMed ID: 1998789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical short-term changes produced by hormonal replacement therapy.
    Aloia JF; Vaswani A; Yeh JK; McGowan DM; Ross P
    J Endocrinol Invest; 1991 Dec; 14(11):927-34. PubMed ID: 1806610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of measurement errors on the diagnostic value of bone mass measurements: theoretical considerations.
    Hassager C; Jensen SB; Gotfredsen A; Christiansen C
    Osteoporos Int; 1991 Sep; 1(4):250-6. PubMed ID: 1790412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits.
    Goddard MK
    Br J Gen Pract; 1992 Mar; 42(356):120-5. PubMed ID: 1493029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and the menopause. Australian Menopause Society.
    MacLennan AH
    Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437
    [No Abstract]   [Full Text] [Related]  

  • 11. Sex steroids and cancer.
    Gambrell RD
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal estrogen replacement and breast cancer.
    Barrett-Connor E
    N Engl J Med; 1989 Aug; 321(5):319-20. PubMed ID: 2747772
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer in postmenopausal estrogen-progestogen users.
    Lee NC; Rubin GL
    Obstet Gynecol; 1984 Dec; 64(6):832-4. PubMed ID: 6504429
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer and the use of estrogens.
    Gambrell RD
    Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone replacement therapy and breast cancer--any news?].
    Holli K
    Duodecim; 1999; 115(2):101-2. PubMed ID: 11830839
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.